ArticleFrontiers in neurology2025
Resting-state EEG and machine learning to investigate cortical connectivity as a biomarker in chronic mTBI.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Introduction: Mild traumatic brain injury (mTBI) is a heterogeneous condition with long-term sequelae, yet diagnosis in the chronic stage remains limited by reliance on acute criteria and subjective reports. Objective biomarkers are needed, as current blood-based markers show diagnostic value primarily in the acute and subacute phases. Resting-state EEG (RS-EEG) can capture large-scale network disruptions through functional connectivity (FC) and microstate analysis, but its role in chronic mTBI is unclear. Methods: We tested whether RS-EEG features distinguish chronic mTBI from controls and predict symptom burden. This observational case-control study included 44 participants (18 chronic mTBI, 26 controls). Source-reconstructed EEG was analyzed for spectral power, microstate metrics, and FC using the Multivariate Interaction Measure (MIM). Elastic Net and XGBoost models classified injury status and predicted symptom severity, with feature robustness evaluated across full and reduced electrode montages. Results: Participants with mTBI showed no group differences in spectral power or microstate metrics but demonstrated significantly elevated FC across theta, beta, gamma, and broadband frequencies. Connectivity increases were stable across reduced montages and persisted up to 8 years post-injury. Classification models using MIM achieved AUCs of 0.79-0.89 for injury status and 0.82-0.87 for symptom severity, outperforming demographic models. Resting-state EEG FC provides a sensitive biomarker of chronic mTBI, distinguishing cases from controls and correlating with symptom severity. Discussion: The persistence of network alterations years after injury suggests lasting changes in brain activity associated with chronic symptom burden. These findings support the use of RS-EEG-derived FC as a noninvasive and scalable biomarker of chronic mTBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.